182 related articles for article (PubMed ID: 11274927)
21. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis.
Airas L; Mikkola J; Vainio JM; Elovaara I; Smith DJ
J Neuroimmunol; 2006 Aug; 177(1-2):132-5. PubMed ID: 16806498
[TBL] [Abstract][Full Text] [Related]
22. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
Bono P; Salmi M; Smith DJ; Jalkanen S
J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
[TBL] [Abstract][Full Text] [Related]
23. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.
Aalto K; Autio A; Kiss EA; Elima K; Nymalm Y; Veres TZ; Marttila-Ichihara F; Elovaara H; Saanijoki T; Crocker PR; Maksimow M; Bligt E; Salminen TA; Salmi M; Roivainen A; Jalkanen S
Blood; 2011 Sep; 118(13):3725-33. PubMed ID: 21821708
[TBL] [Abstract][Full Text] [Related]
24. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
25. Association of HMGB1 with oxidative stress markers and regulators in PDR.
Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
[TBL] [Abstract][Full Text] [Related]
26. Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.
Silvola JM; Virtanen H; Siitonen R; Hellberg S; Liljenbäck H; Metsälä O; Ståhle M; Saanijoki T; Käkelä M; Hakovirta H; Ylä-Herttuala S; Saukko P; Jauhiainen M; Veres TZ; Jalkanen S; Knuuti J; Saraste A; Roivainen A
Sci Rep; 2016 Oct; 6():35089. PubMed ID: 27731409
[TBL] [Abstract][Full Text] [Related]
27. Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.
Nurminen EM; Pihlavisto M; Lázár L; Pentikäinen U; Fülöp F; Pentikäinen OT
J Med Chem; 2011 Apr; 54(7):2143-54. PubMed ID: 21405023
[TBL] [Abstract][Full Text] [Related]
28. Carbohydrates located on the top of the "cap" contribute to the adhesive and enzymatic functions of vascular adhesion protein-1.
Maula SM; Salminen T; Kaitaniemi S; Nymalm Y; Smith DJ; Jalkanen S
Eur J Immunol; 2005 Sep; 35(9):2718-27. PubMed ID: 16082728
[TBL] [Abstract][Full Text] [Related]
29. VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: implications for antiadhesive applications.
Koskinen K; Nevalainen S; Karikoski M; Hänninen A; Jalkanen S; Salmi M
J Immunol; 2007 Nov; 179(9):6160-8. PubMed ID: 17947691
[TBL] [Abstract][Full Text] [Related]
30. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
31. Vascular adhesion protein-1 in human ischaemic stroke.
Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
[TBL] [Abstract][Full Text] [Related]
32. Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
Pannecoeck R; Serruys D; Benmeridja L; Delanghe JR; van Geel N; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2015; 52(6):284-300. PubMed ID: 26287391
[TBL] [Abstract][Full Text] [Related]
33. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
34. [Vascular adhesion protein-1: an unusual adhesion molecule].
Madej A; Reich A; Szepietowski J
Postepy Hig Med Dosw (Online); 2005; 59():172-9. PubMed ID: 15928600
[TBL] [Abstract][Full Text] [Related]
35. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells.
Salmi M; Jalkanen S
J Exp Med; 1996 Feb; 183(2):569-79. PubMed ID: 8627168
[TBL] [Abstract][Full Text] [Related]
36. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
[TBL] [Abstract][Full Text] [Related]
37. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
Salmi M; Jalkanen S
Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation.
Autio A; Vainio PJ; Suilamo S; Mali A; Vainio J; Saanijoki T; Noponen T; Ahtinen H; Luoto P; Teräs M; Jalkanen S; Roivainen A
J Nucl Med; 2013 Aug; 54(8):1315-9. PubMed ID: 23847292
[TBL] [Abstract][Full Text] [Related]
39. Vascular adhesion protein-1 and microvascular diabetic complications.
Singh AD; Kulkarni YA
Pharmacol Rep; 2022 Feb; 74(1):40-46. PubMed ID: 35001320
[TBL] [Abstract][Full Text] [Related]
40. VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice.
Ferjančič Š; Gil-Bernabé AM; Hill SA; Allen PD; Richardson P; Sparey T; Savory E; McGuffog J; Muschel RJ
Blood; 2013 Apr; 121(16):3289-97. PubMed ID: 23407548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
